Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis - Leucht, Stefan; Cipriani, Andrea; Spineli, Loukia; Mavridis, Dimitris; Örey, Deniz; Richter, Franziska; Samara, Myrto; Barbui, Corrado; Engel, Rolf R; Geddes, John R; Kissling, Werner; Stapf, Marko Paul; et al. (The Lancet (British edition), 2013)
Keywords: Adult; Adult and adolescent clinical studies; adverse effects; Antipsychotic Agents - therapeutic use; Antipsychotics; Bias; Biological and medical sciences; chlorpromazine; Drug dosages; Food and Drug Administration; General aspects; guidelines; haloperidol; Health policy; Humans; Internal Medicine; Internet; Medical research; Medical sciences; Mental disorders; mental health; Meta-analysis; Neuropharmacology; odds ratio; patients; Pharmaceutical industry; Pharmacology. Drug treatments; prolactin; Psycholeptics: tranquillizer, neuroleptic; Psychology. Psychoanalysis. Psychiatry; Psychopathology. Psychiatry; Psychopharmacology; Psychoses; Psychotropic drugs; randomized clinical trials; Randomized Controlled Trials as Topic; risk; Schizophrenia; Schizophrenia - drug therapy; sedation; Sensitivity analysis; Side effects; Statistical analysis; Studies; Systematic review; Treatment Outcome; United States; weight gain; United States; United States--US; Psychosis; Medicine; Chemotherapy; Treatment; Multiple; Neuroleptic; Psychotropic; Treatment efficiency; Schizophrenia; Antipsychotic; Comparative study; Metaanalysis